By the end of WEEK 13, students will be able to:
22. Discuss how the (drug) information is used in decision making for the patient.
23. Define Drug Utilization Evaluation (DUE) and detail the processes involved.
24. Discuss the development of criteria for DUE.
25. Discuss the types of drugs given priority for DUE.
26. Define Drug Utilization Review (DUR) and differentiate between prospective DUR (ProDUR) and retrospective DUR (RDUR).
27. Discuss the goals of ProDUR and RDUR.
28. Detail the guidelines for institutional pharmacy research.
Readings, Resources, Activities
Textbook Chapters 5, 6
Checkpoint Question (1)
22. Discuss how the (drug) information is used in decision making for the patient.
23. Define Drug Utilization Evaluation (DUE) and detail the processes involved.
24. Discuss the development of criteria for DUE.
25. Discuss the types of drugs given priority for DUE.
26. Define Drug Utilization Review (DUR) and differentiate between prospective DUR (ProDUR) and retrospective DUR (RDUR).
27. Discuss the goals of ProDUR and RDUR.
28. Detail the guidelines for institutional pharmacy research.
Readings, Resources, Activities
Textbook Chapters 5, 6
Checkpoint Question (1)